| Literature DB >> 35564572 |
Ryuichi Shirahase1,2, Yutaka Watanabe1, Tohru Saito2, Yusuke Sunakawa1,2, Yuya Matsushita1,2, Hideki Tsugayasu2, Yutaka Yamazaki1.
Abstract
We aimed to clarify the relationship between oral function assessments regarding oral hypofunction and sarcopenia in patients who had completed treatment for organic dental problems, including oral pain, removable denture fit, and tooth loss. This cross-sectional study included 269 patients aged ≥65 years (mean age 74.9 ± 6.50 years, 133 men, 136 women) who visited a dental clinic between June 2019 and March 2021. We evaluated oral function and sarcopenia and analyzed their relationship using the Jonckheere-Terpstra test, Mantel-Haenszel trend test, and Poisson regression analysis. We diagnosed 132 (49.07%) patients with oral hypofunction, 30 (11.2%) with sarcopenia, and 24 (8.9%) with severe sarcopenia. The number of oral hypofunction items (prevalence rate ratio [PRR] = 1.39, 95%Wald = 0.11 to 0.56) was significantly associated with sarcopenia. For each of the items, tongue-lip motor function [ta] (PRR = 0.80, 95%Wald = -0.44 to -0.02)] [ka] (PRR = 0.76, 95%Wald = -0.53 to -0.03) and tongue pressure (PRR = 0.95, 95%Wald = -0.09 to -0.02) showed a significant association with sarcopenia. However, no significant association was found for other variables. Dentists should not only treat organic dental problems but also consider the relationship between oral function and sarcopenia.Entities:
Keywords: mobility-impaired dental problems; oral hypofunction; organic dental problems; sarcopenia; super-aged society
Mesh:
Year: 2022 PMID: 35564572 PMCID: PMC9099729 DOI: 10.3390/ijerph19095178
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Selection of adjustment variables by directed acyclic graph.
Figure 2AWGS2019 criteria for the diagnosis of sarcopenia.
Items for oral function assessment and the number and percentage of patients with oral hypofunction.
| Clinical Signs | Measurement | Number | % |
|---|---|---|---|
| Poor oral hygiene | Tongue coating index ≥ 50% | 52 | 19.33 |
| Oral dryness | The measured value obtained by a recommended moisture checker is less than 27.0. | 115 | 42.75 |
| Reduced occlusal force | The number of remaining teeth is less than 20. | 131 | 48.70 |
| Decreased tongue-lip motor function | The number of /pa/, /ta/ or /ka/ pronunciations per second is less than 6. | 170 | 63.20 |
| Decreased tongue pressure | The maximum tongue pressure is less than 30 kPa. | 130 | 48.33 |
| Decreased masticatory function | The glucose concentration obtained by chewing gelatin gummies is less than 100 mg/dL. | 21 | 7.80 |
| Decreased swallowing function | The A items on the Seirei dysphagia screening questionnaire more than 1. | 68 | 25.30 |
Trends in participant characteristics among the study groups.
| All | Normal | Sarcopenia | Severe Sarcopenia | Analysis | ||
|---|---|---|---|---|---|---|
| Variables | ( | ( | ( | ( | ||
|
| ||||||
| Age | 74.93 ± 6.50 | 73.94 ± 6.03 | 77.17 ± 6.64 | 80.96 ± 6.62 | <0.001 *** | a |
| Sex (%, male) | 49.44 | 46.05 | 56.67 | 70.83 | 0.016 * | b |
| Height (cm) | 157.22 ± 8.79 | 158.01 ± 8.77 | 152.45 ± 7.22 | 155.41 ± 8.83 | 0.005 ** | a |
| Weight (kg) | 59.05 ± 10.61 | 60.58 ± 9.76 | 52.04 ± 12.45 | 54.10 ± 10.91 | <0.001 *** | a |
| BMI (kg/m2) | 23.59 ± 3.29 | 24.14 ± 3.22 | 21.52 ± 3.03 | 21.25 ± 1.97 | <0.001 *** | a |
|
| ||||||
| Grip strength (kg) | 28.13 ± 11.96 | 29.44 ± 11.89 | 25.83 ± 13.01 | 19.31 ± 5.80 | <0.001 *** | a |
| Gait speed (m/s) | 1.06 ± 0.27 | 1.10 ± 0.26 | 1.02 ± 0.23 | 0.78 ± 0.23 | <0.001 *** | a |
| SMI (kg/m2) | 6.67 ± 0.96 | 6.85 ± 0.92 | 5.85 ± 0.80 | 5.99 ± 0.66 | <0.001 *** | a |
|
| ||||||
| Oral hygiene (%) | 32.48 ± 17.26 | 32.36 ± 16.87 | 32.15 ± 21.36 | 34.03 ± 15.66 | 0.844 | a |
| Oral dryness | 26.91 ± 3.09 | 27.03 ± 3.09 | 26.87 ± 2.80 | 25.94 ± 3.43 | 0.136 | a |
| Number of remaining teeth | 17.25 ± 8.81 | 17.99 ± 8.41 | 14.13 ± 9.83 | 14.63 ± 9.96 | 0.016 * | a |
| Tongue-lip motor function/pa/ (times/s) | 6.09 ± 0.96 | 6.23 ± 0.83 | 5.75 ± 0.99 | 5.36 ± 1.51 | <0.001 *** | a |
| /ta/ (times/s) | 6.04 ± 0.93 | 6.15 ± 0.86 | 5.68 ± 0.83 | 5.48 ± 1.34 | <0.001 *** | a |
| /ka/ (times/s) | 5.92 ± 0.95 | 5.75 ± 0.85 | 5.17 ± 0.95 | 4.98 ± 1.32 | <0.001 *** | a |
| Tongue pressure (KPa) | 30.27 ± 8.27 | 31.50 ± 7.88 | 27.65 ± 8.56 | 22.51 ± 6.40 | <0.001 *** | a |
| Masticatory function (mg/dL) | 182.87 ± 59.53 | 187.37 ± 59.88 | 161.30 ± 39.30 | 169.50 ± 70.74 | 0.013 * | a |
| Swallowing function (%) † | 25.29 | 21.40 | 30.00 | 54.17 | 0.001 ** | b |
| Number of oral hypofunction items | 2.55 ± 1.31 | 2.34 ± 1.21 | 3.03 ± 1.19 | 3.75 ± 1.51 | <0.001 *** | a |
| Diagnosis of oral hypofunction (%) | 49.07 | 43.72 | 64.52 | 75.00 | 0.001 ** | b |
| Number of functional teeth | 27.53 ± 1.01 | 27.56 ± 0.96 | 27.50 ± 1.22 | 27.29 ± 1.16 | 0.698 | a |
| Removable denture use (%) | 64.68 | 64.65 | 64.52 | 62.50 | 0.926 | b |
|
| ||||||
| Hypertension (%) | 26.77 | 27.91 | 16.13 | 29.17 | 0.677 | b |
| Diabetes mellitus (%) | 12.27 | 9.30 | 16.13 | 33.33 | 0.001 ** | b |
| Hyperlipidemia (%) | 12.27 | 12.56 | 9.68 | 12.50 | 0.865 | b |
| Cerebrovascular disease (%) | 6.32 | 4.65 | 9.68 | 16,67 | 0.014 * | b |
| Cardiovascular disease (%) | 11.15 | 11.63 | 6.45 | 12.50 | 0.269 | b |
| Cancer (%) ‡ | 5.95 | 6.05 | 9.68 | 0.00 | 0.498 | b |
BMI, body mass index; SMI, skeletal muscle mass index. a. Jonckheere–Terpstra trend test. b. Mantel–Haenszel trend test. * p < 0.05, ** p < 0.01, *** p < 0.001. † Percentage of patients with reduced swallowing function. ‡ Exclude head and neck cancer.
Relationship between sarcopenia and age, BMI, sex, and medical history.
| Variables | PPR | 95%Wald | ||
|---|---|---|---|---|
| Lower Limit | Upper Limit | |||
| Age | 1.09 | 0.05 | 0.12 | <0.001 *** |
| BMI | 0.81 | −0.30 | −0.13 | <0.001 *** |
| Sex | 1.73 | −0.01 | 1.10 | 0.053 |
| Hypertension | 0.78 | −0.89 | 0.39 | 0.443 |
| Diabetes mellitus | 2.34 | 0.23 | 1.47 | 0.008 ** |
| Hyperlipidemia | 0.89 | −0.97 | 0.73 | 0.788 |
| Cerebrovascular disease | 2.20 | −0.01 | 1.58 | 0.052 |
| Cancer | 0.93 | −1.24 | 1.09 | 0.898 |
| Cardiovascular disease | 0.81 | −1.13 | 0.71 | 0.653 |
** p < 0.01, *** p < 0.001. Poisson regression analysis was performed. Dependent variable: two sarcopenia groups. Independent variables: age, BMI, sex, hypertension, diabetes, dyslipidemia, cerebrovascular disease, cancer, and cardiovascular disease. PRR. prevalence rate ratio.
Relationship between sarcopenia and oral function assessment, removable denture use, number of functional teeth, diagnosis of oral hypofunction, and number of oral hypofunction items.
| Variables | Model 1 | Model 2 | ||||||
|---|---|---|---|---|---|---|---|---|
| 95% Wald | 95% Wald | |||||||
| PRR | Lower Limit | Upper Limit | PRR | Lower Limit | Upper Limit | |||
|
| 1.00 | −0.01 | 0.02 | 0.816 | 1.00 | −0.02 | 0.02 | 0.861 |
|
| 0.96 | −0.12 | 0.04 | 0.281 | 0.97 | −0.11 | 0.05 | 0.404 |
|
| 0.97 | −0.06 | −0.07 | 0.017 * | 0.99 | −0.05 | 0.02 | 0.359 |
|
| 0.69 | −0.56 | −0.19 | <0.001 *** | 0.80 | −0.44 | −0.02 | 0.035 * |
|
| 0.68 | −0.61 | −0.17 | <0.001 *** | 0.80 | −0.48 | 0.02 | 0.070 |
|
| 0.64 | −0.65 | −0.23 | <0.001 *** | 0.76 | −0.53 | −0.03 | 0.029 * |
|
| 0.93 | −0.10 | −0.04 | <0.001 *** | 0.95 | −0.09 | −0.02 | 0.003 ** |
|
| 1.00 | −0.01 | −0.00 | 0.027 * | 1.00 | −0.01 | 0.00 | 0.207 |
|
| 2.02 | 0.16 | 1.25 | 0.011 * | 1.60 | −0.10 | 1.04 | 0.108 |
|
| 1.01 | −0.55 | 0.57 | 0.968 | 0.81 | −0.79 | 0.36 | 0.467 |
|
| 0.90 | −0.33 | 0.13 | 0.374 | 0.89 | −0.34 | 0.10 | 0.296 |
|
| 2.45 | 0.31 | 1.48 | 0.003 ** | 1.63 | −0.14 | 1.12 | 0.127 |
|
| 1.57 | 0.25 | 0.65 | <0.001 *** | 1.39 | 0.11 | 0.56 | 0.004 ** |
Model 1. Poisson logistic regression analysis was performed. Dependent variable: two sarcopenia groups. Independent variables: each item of the oral function assessment and the number of functional teeth, removable denture use, diagnosis of oral hypofunction, and the number of oral hypofunction items. Model 2. In addition to model 1, age, sex, diabetes mellitus, and cerebrovascular disease were entered as covariates. * p < 0.05, ** p < 0.01, *** p < 0.001.